These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8549394)
1. Causative organisms in acute exacerbation of chronic airways disease and response to ofloxacin therapy. Sufarlan AW; Zainudin BM; Pit S; Ishak I Drugs; 1995; 49 Suppl 2():442-5. PubMed ID: 8549394 [No Abstract] [Full Text] [Related]
2. Inhibitory effect of ofloxacin on acute exacerbations of chronic respiratory tract infections in comparison with erythromycin. Kawahara S; Watanabe Y; Matsuka Y; Sato T; Takahashi K Drugs; 1995; 49 Suppl 2():414-5. PubMed ID: 8549382 [No Abstract] [Full Text] [Related]
3. Clinical efficacy of ofloxacin in acute exacerbations of chronic respiratory disease. Watanabe K; Yoshida M; Ishibashi T; Yamada H; Kido M; Hirose T; Maeda F; Matsuzaki Y Drugs; 1995; 49 Suppl 2():448-50. PubMed ID: 8549396 [No Abstract] [Full Text] [Related]
4. A comparative study of ofloxacin twice and three times daily in the treatment of respiratory tract infections. Sawae Y; Ninomiya K; Takaki K; Shimono N; Misumi H; Okada K Drugs; 1995; 49 Suppl 2():430-2. PubMed ID: 8549390 [No Abstract] [Full Text] [Related]
5. Levofloxacin in patients with severe respiratory tract infection. Odagiri S Drugs; 1995; 49 Suppl 2():426-7. PubMed ID: 8549387 [No Abstract] [Full Text] [Related]
6. Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections. Nakamori Y; Miyashita Y; Nakatani I; Nakata K Drugs; 1995; 49 Suppl 2():418-9. PubMed ID: 8549384 [No Abstract] [Full Text] [Related]
7. Clinical efficacy of levofloxacin in elderly patients with respiratory tract infections. Sato A; Ogawa H; Iwata M; Ono T; Yasuda K; Nagayama M; Shirai T; Shirai M; Ida M; Suda T Drugs; 1995; 49 Suppl 2():428-9. PubMed ID: 8549388 [No Abstract] [Full Text] [Related]
8. Clinical evaluation of levofloxacin 200 mg 3 times daily in the treatment of bacterial lower respiratory tract infections. Kawai T Drugs; 1995; 49 Suppl 2():416-7. PubMed ID: 8549383 [No Abstract] [Full Text] [Related]
14. A comparative study of ofloxacin versus cefazolin in lower respiratory tract infections. Bariffi F; Giacomelli P; Sanduzzi A; Perna F; De Masi AL Int J Clin Pharmacol Res; 1987; 7(3):199-201. PubMed ID: 3474212 [TBL] [Abstract][Full Text] [Related]
15. [Treatment in general practice. Effective, well tolerated therapy]. MMW Fortschr Med; 2000 Sep; 142(37):58-9. PubMed ID: 11026226 [No Abstract] [Full Text] [Related]
16. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation. Liam CK; Aziah AM; Lim KH; Wong CM Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708 [TBL] [Abstract][Full Text] [Related]
17. Ofloxacin in cystic fibrosis. Meyer H Drugs; 1987; 34 Suppl 1():177-9. PubMed ID: 3481319 [No Abstract] [Full Text] [Related]
18. Clinical evaluation of ofloxacin in lower respiratory tract infections. Kobayashi H Infection; 1986; 14 Suppl 4():S279-82. PubMed ID: 3469163 [TBL] [Abstract][Full Text] [Related]
19. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients. Spivey IM Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817 [No Abstract] [Full Text] [Related]
20. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Langtry HD; Lamb HM Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]